Recursion Pharmaceuticals Inc Clas (RXRX)
Net Receivables
$14.39M
Quarterly · Period ending: · USD
RXRX Net Receivables
Latest reported$14.39Mperiod ending
Latest reported$14.39Mperiod ending
RXRX Quarterly Net Receivables ($0.00 → $14.39M)
Quarterly net receivables
High-resolution chart · PNG
RXRX net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 14,393,000 | |
| 13,585,000 | |
| 24,649,000 | |
| 21,910,000 | |
| 21,606,000 | |
| 46,124,000 | |
| 49,166,000 | |
| 2,255,000 | |
| 2,526,000 | |
| 2,599,000 | |
| 3,094,000 | |
| 3,164,000 | |
| 3,051,000 | |
| 2,057,000 | |
| 2,753,000 | |
| 11,635,000 | |
| 11,680,000 | |
| 11,397,000 | |
| 9,090,000 | |
| 2,282,000 | |
| 49,000 | |
| 71,000 | |
| 156,000 | |
| 0 |